Policy & Regulation News

The ginseng supplement can help to support cognitive health.

Patients will be able to take the drug twice rather than three times daily.

The National Physician Payment Transparency Program aims to pull back the curtain on physician-pharmaceuticals relations.

The US Food and Drug Administration (FDA) has now issued the guidance for Industry on Clinical Pharmacogenomics which refers to a Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for labelling.

The Union health ministry has constituted two expert committees to formulate policy guidelines and standard operating procedures (SOPs) for approval of new drugs, clinical trials, banning of drugs and Fixed Dose Combinations (FDCs).

Parliamentary panel attached to the Ministry of Chemicals and Fertilisers has asked the Ministry to check on quality of drugs.

The European Medicines Agency has published a plan to help the European medicines regulatory network deal with supply shortages of medicines following manufacturing problems.

Janssen R&D has launched a new databank that should help pharmaceutical companies to identify appropriate clinical trial sites more efficiently.

The National Pharmaceutical Pricing Authority (NPPA) has brought down the prices of anti-diabetic bulk drug glipizide considerably, increased the prices of four other bulk drugs, and revised the prices of 92 formulations.

Pushed by the Supreme Court to finalise the National Pharmaceutical Pricing Policy before November 27, the Group of Ministers (GoM) on Wednesday claimed to have settled the differences among the key ministries over the pricing mechanism and vowed to an...